dc.contributor.author |
Stark, Roderick T.
|
|
dc.contributor.author |
Pye, Dominic R.
|
|
dc.contributor.author |
Chen, Wenyi
|
|
dc.contributor.author |
Newton, Oliver J.
|
|
dc.contributor.author |
Deadman, Benjamin J.
|
|
dc.contributor.author |
Miller, Philip W.
|
|
dc.contributor.author |
Panayides, Jenny-Lee
|
|
dc.contributor.author |
Riley, Darren Lyall
|
|
dc.contributor.author |
Hellgardt, Klaus
|
|
dc.contributor.author |
Hii, King Kuok (Mimi)
|
|
dc.date.accessioned |
2023-10-16T07:37:26Z |
|
dc.date.available |
2023-10-16T07:37:26Z |
|
dc.date.issued |
2022-10 |
|
dc.description.abstract |
A synthetic route to an anti-cancer drug, lapatinib, was devised to support the development of a
sustainable manufacturing process in South Africa. Quantitative metrics were employed to evaluate the
sustainability of the key steps of the reaction. |
en_US |
dc.description.department |
Chemistry |
en_US |
dc.description.librarian |
am2023 |
en_US |
dc.description.sponsorship |
The ROAR facility by EPSRC. |
en_US |
dc.description.uri |
https://pubs.rsc.org/en/journals/journalissues/re |
en_US |
dc.identifier.citation |
Stark, R.T., Pye, D.R., Chen, W. et al. 2022, 'Assessing a sustainable manufacturing route to lapatinib', Reaction Chemistry and Engineering, vol. 7, no. 11, pp. 2420-2426, doi : 10.1039/d2re00267a. |
en_US |
dc.identifier.issn |
2058-9883 (online) |
|
dc.identifier.other |
10.1039/d2re00267a |
|
dc.identifier.uri |
http://hdl.handle.net/2263/92873 |
|
dc.language.iso |
en |
en_US |
dc.publisher |
Royal Society of Chemistry |
en_US |
dc.rights |
© The Royal Society of Chemistry 2022.
This article is licensed under a Creative Commons Attribution 3.0 Unported Licence. |
en_US |
dc.subject |
Anti-cancer drug |
en_US |
dc.subject |
Lapatinib |
en_US |
dc.subject |
Quantitative metrics |
en_US |
dc.subject |
SDG-03: Good health and well-being |
en_US |
dc.subject |
South Africa (SA) |
en_US |
dc.title |
Assessing a sustainable manufacturing route to lapatinib |
en_US |
dc.type |
Article |
en_US |